Avecho Biotechnology Ltd (AVE) — Capital Reinvestment Ratio

Latest as of December 2019: 0.00x

Avecho Biotechnology Ltd (AVE) has a Capital Reinvestment Ratio of 0.00x as of December 2019, meaning it reinvests 0% of its operating cash flow (AU$1.19 Million) in capital expenditures (AU$5.15K). See AVE equity financing ratio to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.00x
Capex / Operating Cash Flow

Operating Cash Flow

AU$1.19 Million
AUD

Capital Expenditures

AU$5.15K
AUD

Data as of

Dec 2019
Most recent filing

Avecho Biotechnology Ltd Capital Reinvestment Ratio (2019–2019)

This chart tracks Avecho Biotechnology Ltd's Capital Reinvestment Ratio across 1 annual periods. Check Avecho Biotechnology Ltd (AVE) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Avecho Biotechnology Ltd (2019–2019)

Year-by-year Capital Reinvestment Ratio for Avecho Biotechnology Ltd from 2019 to 2019. For live market cap and broader valuation context, see Avecho Biotechnology Ltd (AVE) total market value.

Year Reinvestment Ratio Operating CF (AUD) Capital Expenditures YoY Change
2019 0.00x AU$1.19 Million AU$5.15K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow